Clinical Trials Study
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Jun 25, 2015; 7(7): 747-757
Published online Jun 25, 2015. doi: 10.4253/wjge.v7.i7.747
Management of liver transplantation biliary stricture: Results from a tertiary hospital
Fernanda Prata Martins, Michel Kahaleh, Angelo P Ferrari
Fernanda Prata Martins, Angelo P Ferrari, Endoscopy Unit, Hospital Israelita Albert Einstein, São Paulo-SP 05652-900, Brazil
Michel Kahaleh, Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, United States
Angelo P Ferrari, Division of Gastroenterology, Universidade Federal de São Paulo, São Paulo-SP 05652-900, Brazil
Author contributions: Martins FP contributed to the design, acquisition of data and wrote the manuscript; Kahaleh M contributed to the writing and revision of the manuscript; Ferrari AP designed the aim and contributed to the writing and revision of the manuscript; all authors provided final approval of the version to be published.
Supported by Boston Scientific, EMcison, Xlumena, MaunaKea Tech, MI Tech, Apollo Endosurgery, Cook Endoscopy, W.L. Gore Associates, GI Dynamics and ASPIRE Bariatrics (Kahaleh M).
Ethics approval: The study was reviewed and approved by the Hospital Israelita Albert Einstein Institutional Review Board. This study is registered at https://clinicaltrials.gov.
Clinical trial registration: The registration identification number is NCT01148199.
Informed consent: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest: Fernanda Prata Martins has no conflict of interest to disclosure. Angelo Paulo Ferrari is a Medical Advisory Board Member for Boston Scientific do Brasil.
Data sharing: Technical appendix, statistical code, and dataset available from the corresponding author at https://datadryad.org. Consent for data sharing was not obtained but the presented data are anonymized and risk of identification is low. No additional data are available. Statistical data analysis was performed by the author (Martins FP) and reviewed by Hospital Israelita Albert Einstein Statistics Department.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Fernanda Prata Martins, MD, PhD, Endoscopy Unit, Hospital Israelita Albert Einstein, Rua Barata Ribeiro, 490 cj 118, São Paulo-SP 05652-900, Brazil. fernandapbm@gmail.com
Telephone: +55-11-981936251 Fax: +55-11-38877997
Received: August 28, 2014
Peer-review started: August 28, 2014
First decision: September 16, 2014
Revised: April 30, 2015
Accepted: May 8, 2015
Article in press: May 10, 2015
Published online: June 25, 2015
Abstract

AIM: To review results of endoscopic treatment for anastomotic biliary strictures after orthotopic liver transplantation (OLT) during an 8-year period.

METHODS: This is a retrospective review of all endoscopic retrograde cholangiopancreatographys (ERCPs) performed between May 2006 and June 2014 in deceased OLT recipients with anastomotic stricture at a tertiary care hospital. Patients were divided into 2 groups, according to the type of stent used (multiple plastic or covered self-expandable metal stents), which was chose on a case-by-case basis and their characteristics. The primary outcome was anastomotic stricture resolution rate determined if there was no more than a minimum waist at cholangiography and a 10 mm balloon could easily pass through the anastomosis with no need for further intervention after final stent removal. Secondary outcomes were technical success rate, number or ERCPs required per patient, number of stents placed, stent indwelling, stricture recurrence rate and therapy for recurrent anastomotic biliary stricture (AS). Stricture recurrence was defined as clinical laboratorial and/or imaging evidence of obstruction at the anastomosis level, after it was considered completely treated, requiring subsequent interventional procedure.

RESULTS: A total of 195 post-OLT patients were assessed for eligibility. One hundred and sixty-four (164) patients were diagnosed with anastomotic biliary stricture. ERCP was successfully performed in 157/164 (95.7%) patients with AS, that were treated with either multiple plastic (n = 109) or metallic billiary stents (n = 48). Mean treatment duration, number of procedures and stents required were lower in the metal stent group. Acute pancreatitis was the most common procedure related complication, occurring in 17.1% in the covered self-expandable metal stents (cSEMS) and 4.1% in the multiple plastic stent (MPS) group. Migration was the most frequent stent related complication, observed in 4.3% and 5.5% (cSEMS and MPS respectively). Stricture resolution was achieved in 86.8% in the cSEMS group and in 91% in MPS group. Stricture recurrence after a median follow up of 20 mo was observed in 10 (30.3%) patients in the cSEMS and 7 (7.7%) in the plastic stent group, a statistically significant difference (P = 0.0017). Successful stricture resolution after secondary treatment was achieved in 66.6% and 62.5% of patients respectively in the cSEMS and plastic stents groups.

CONCLUSION: Multiple plastic stents are currently the first treatment option for AS in patients with duct-to-duct anastomosis. cSEMS was associated with increased pancreatitis risk and higher recurrence rate.

Keywords: Biliary stricture, Benign, Liver transplant, Endoscopic retrograde cholangiopancreatographys, Endoscopic treatment, Plastic stent, Self-expandable metal stent

Core tip: Endoscopic treatment is effective and safe in the management of post liver transplant biliary complications, mainly for anastomotic strictures. Progressive dilation and multiple plastic stenting have been demonstrated as the best endoscopic therapeutic modality with high success rates and low recurrence. Fully covered stent-expandable metal stents may be an option for endoscopic therapy potentially reducing the number and procedures lowering the costs, however their complication rate needs to be further evaluated.